BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34399806)

  • 1. Investigation of the clinical inter-observer bias in prostate fiducial marker image registration between CT and MR images.
    Persson E; Emin S; Scherman J; Jamtheim Gustafsson C; Brynolfsson P; Ceberg S; Gunnlaugsson A; Olsson LE
    Radiat Oncol; 2021 Aug; 16(1):150. PubMed ID: 34399806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using C-Arm X-ray images from marker insertion to confirm the gold fiducial marker identification in an MRI-only prostate radiotherapy workflow.
    Gustafsson C; Persson E; Gunnlaugsson A; Olsson LE
    J Appl Clin Med Phys; 2018 Nov; 19(6):185-192. PubMed ID: 30354010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of an MR-only workflow for prostate radiotherapy using semi-automatically burned-in fiducial markers.
    Goudschaal K; Beeksma F; Boon M; Bijveld M; Visser J; Hinnen K; van Kesteren Z
    Radiat Oncol; 2021 Feb; 16(1):37. PubMed ID: 33608008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Registration free automatic identification of gold fiducial markers in MRI target delineation images for prostate radiotherapy.
    Gustafsson C; Korhonen J; Persson E; Gunnlaugsson A; Nyholm T; Olsson LE
    Med Phys; 2017 Nov; 44(11):5563-5574. PubMed ID: 28803447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration.
    Parker CC; Damyanovich A; Haycocks T; Haider M; Bayley A; Catton CN
    Radiother Oncol; 2003 Feb; 66(2):217-24. PubMed ID: 12648794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR-PROTECT: Clinical feasibility of a prostate MRI-only radiotherapy treatment workflow and investigation of acceptance criteria.
    Persson E; Jamtheim Gustafsson C; Ambolt P; Engelholm S; Ceberg S; Bäck S; Olsson LE; Gunnlaugsson A
    Radiat Oncol; 2020 Apr; 15(1):77. PubMed ID: 32272943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of manual and automatic MR-CT registration for radiotherapy of prostate cancer.
    Korsager AS; Carl J; Riis Østergaard L
    J Appl Clin Med Phys; 2016 May; 17(3):294-303. PubMed ID: 27167285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI.
    Pathmanathan AU; Schmidt MA; Brand DH; Kousi E; van As NJ; Tree AC
    J Appl Clin Med Phys; 2019 Mar; 20(3):27-36. PubMed ID: 30756456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy.
    Maspero M; Seevinck PR; Willems NJW; Sikkes GG; de Kogel GJ; de Boer HCJ; van der Voort van Zyp JRN; van den Berg CAT
    Radiat Oncol; 2018 Jun; 13(1):105. PubMed ID: 29871656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automatic Substitute Computed Tomography Generation and Contouring for Magnetic Resonance Imaging (MRI)-Alone External Beam Radiation Therapy From Standard MRI Sequences.
    Dowling JA; Sun J; Pichler P; Rivest-Hénault D; Ghose S; Richardson H; Wratten C; Martin J; Arm J; Best L; Chandra SS; Fripp J; Menk FW; Greer PB
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1144-53. PubMed ID: 26581150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a deformable MRI to CT registration algorithm employing same day planning MRI for surrogate analysis.
    Padgett KR; Stoyanova R; Pirozzi S; Johnson P; Piper J; Dogan N; Pollack A
    J Appl Clin Med Phys; 2018 Mar; 19(2):258-264. PubMed ID: 29476603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of automatic deformable structure propagation for high-field MRI guided prostate radiotherapy.
    Christiansen RL; Dysager L; Bertelsen AS; Hansen O; Brink C; Bernchou U
    Radiat Oncol; 2020 Feb; 15(1):32. PubMed ID: 32033574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fiducial marker for prostate radiotherapy: comparison of 0.35- and 0.5-mm-diameter computed tomography and magnetic resonance images.
    Tanaka O; Komeda H; Iida T; Tamaki M; Seike K; Kato D; Hirose S; Kawaguchi D; Yokoyama T
    Radiol Med; 2017 Mar; 122(3):204-207. PubMed ID: 27981486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance only workflow and validation of dose calculations for radiotherapy of prostate cancer.
    Christiansen RL; Jensen HR; Brink C
    Acta Oncol; 2017 Jun; 56(6):787-791. PubMed ID: 28464739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow.
    Mannerberg A; Persson E; Jonsson J; Gustafsson CJ; Gunnlaugsson A; Olsson LE; Ceberg S
    Radiat Oncol; 2020 Jul; 15(1):168. PubMed ID: 32650811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate deformation during hypofractionated radiotherapy: an analysis of implanted fiducial marker displacement.
    Knybel L; Cvek J; Blazek T; Binarova A; Parackova T; Resova K
    Radiat Oncol; 2021 Dec; 16(1):235. PubMed ID: 34876173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial experience with megavoltage (MV) CT guidance for daily prostate alignments.
    Langen KM; Zhang Y; Andrews RD; Hurley ME; Meeks SL; Poole DO; Willoughby TR; Kupelian PA
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1517-24. PubMed ID: 16029814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging for prostate bed radiotherapy planning: An inter- and intra-observer variability study.
    Barkati M; Simard D; Taussky D; Delouya G
    J Med Imaging Radiat Oncol; 2016 Apr; 60(2):255-9. PubMed ID: 26568515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observer uncertainties of soft tissue-based patient positioning in IGRT.
    Hirose TA; Arimura H; Fukunaga JI; Ohga S; Yoshitake T; Shioyama Y
    J Appl Clin Med Phys; 2020 Feb; 21(2):73-81. PubMed ID: 31957964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients.
    Böckelmann F; Putz F; Kallis K; Lettmaier S; Fietkau R; Bert C
    Strahlenther Onkol; 2020 Jul; 196(7):647-656. PubMed ID: 32157345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.